Formula & Concentration

Antihemophilic Factor (Recombinant), PEGylated

Manufacturer

Takeda

Indications

ADYNOVATE, Antihemophilic Factor (Recombinant), PEGylated, is a human antihemophilic factor indicated in children and adults with hemophilia A (congenital factor VIII deficiency) for:

  • On-demand treatment and control of bleeding episodes
  • Perioperative management
  • Routine prophylaxis to reduce the frequency of bleeding episodes

Limitation of Use
ADYNOVATE is not indicated for the treatment of von Willebrand disease. (1)

Product Options

Package Size NDC Presentation
401 IU – 800 IU 00944-4623-01 Vial
750 IU 00944-4626-01 Vial
801 IU – 1250 IU 00944-4624-01 Vial
1801 IU – 2500 IU 00944-4625-01 Vial
1500 IU 00944-4627-01 Vial
3000 IU 00944-4628-01 Vial

Shelf Life & Storage

Store ADYNOVATE in powder form at 2°C to 8°C (36°Fto46°F). Do not freeze. ADYNOVATE may be stored at room temperature not to exceed 30°C (86°F) for a period of up to 3 months not to exceed the expiration date. If stored at room temperature, write the date on the carton when ADYNOVATE is removed from refrigeration. After storage at room temperature,do not return the product to the refrigerator. Do not use beyond expiration date printed on the carton or housing. Store ADYNOVATE in the original box and protect from extreme exposure to light.

ADYNOVATE

Order Online

or call

800-304-3064

Can't find what you are looking for?

Please call us and we would love to help.

800-304-3064